Back to search

Article

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

2021-04-08

Abstract excerpt

<title>Abstract</title> <p>The novel pandemic betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected at least 120 million people since its identification as the cause of a December 2019 viral pneumonia outbreak in Wuhan, China1,2. Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS-CoV-2 ‘variants of concern’...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3263c7cf-fcd7-5c77-9268-1432b2111224
DOI
10.21203/rs.3.rs-400230/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsDOI 10.21203/rs.3.rs-400230/v1
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variantsSemantic proximity
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.Semantic proximity
Evaluation of the Gam-COVID-Vac and Vaccine-Induced Neutralizing Response Against SARS-CoV-2 Lineage P.1 (Manaus) Variant in an Argentinean CohortSemantic proximity
SARS-CoV-2 Variants and Immune Evasion: Mapping the Future of Vaccine Design.Semantic proximity
Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum ProtectionSemantic proximity
A Single Chimeric Spike Antigen Induces Pan-Sarbecovirus ImmunitySemantic proximity
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape over TimeSemantic proximity
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesSemantic proximity
Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccinationSemantic proximity
Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization.Semantic proximity
Broad cross-neutralizing antibodies against animal-associated sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humansSemantic proximity
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 VariantsSemantic proximity
Select a neighboring publication to make it the new centre.